Immunetics, Inc.

CDC collaboration yields new test for anthrax

Published in Drug Law Weekly, June 29th, 2004

A new test funded by the U.S. Centers for Disease Control and Prevention (CDC) and developed in collaboration with a commercial partner has become the first test approved by the U.S. Food and Drug Administration for detecting antibodies to anthrax.

The test, produced by Immunetics, Inc., of Boston, provides an easy-to-use clinical laboratory tool for assessing whether patients have been infected with anthrax.

The Anthrax Quick ELISA test detects antibodies produced during infection with Bacillus anthracis, the bacteria that causes anthrax. The approval shows how cooperative work between government agencies and industry can lead to the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly

Source: Drug Law Weekly (2004-06-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry